Centene Corporation reported its Q4 and full-year 2025 earnings, with an adjusted diluted loss per share of $1.19 for the quarter and $2.08 for the full year. The company expects significant margin improvement and adjusted EPS growth in 2026, forecasting greater than $3. This outlook is driven by Medicaid margin stability, substantial recovery in the marketplace business, and continued progress towards breakeven in Medicare Advantage by 2027.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Centene Corporation (NYSE:CNC) Q4 2025 Earnings Call Transcript
Centene Corporation reported its Q4 and full-year 2025 earnings, with an adjusted diluted loss per share of $1.19 for the quarter and $2.08 for the full year. The company expects significant margin improvement and adjusted EPS growth in 2026, forecasting greater than $3. This outlook is driven by Medicaid margin stability, substantial recovery in the marketplace business, and continued progress towards breakeven in Medicare Advantage by 2027.